Multiplikator Forward P/S: Axogen (AXGN)
AxoGen, Inc. (AXGN) is investing colossal funds into tissue engineering, driving a technological breakthrough in nerve regeneration. The GURU.Markets portal displays this chart, where the forward P/S valuation helps track capitalization, and 12.40 represents the latest level value. Stability is guaranteed by the absence of geopolitical risks, while an impeccable reputation among surgeons has solidified the brand's status as the industry gold standard.
Ringkesan rincian data analitis Axogen Surgical (AXGN)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal AxoGen, Inc.|AXGN - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal AxoGen, Inc.|AXGN - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Axogen Surgical|AXGN - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Axogen|Rasio cepet axogeninc.com
- rincian asil keuangan lan kelipatan valuasi:
AXGN - Penghasilan resik perusahaan|Bathi sing dikarepake AxoGen, Inc.|AXGN - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Axogen Corp|AXGN - Pangali PEG|Pangali EV/EBITDA Axogen Surgical|AXGN - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Axogen|AXGN - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan axogeninc.com|AXGN - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep AxoGen, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:AXGN (Axogen)
Seamless cold chain operations during graft delivery provide AxoGen, Inc. (AXGN) with operational resilience. Analyzing the company's forward P/S chart, an investor can see how the market values the efficiency of these logistics through the lens of expected sales. This metric correlates current market capitalization with projected revenue, measuring the price reaction to future cash flows. A decline in this ratio relative to average values signals that the asset is undervalued.
Karo sapa AxoGen, Inc. saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Corp) - Multiplikator forward rega marang pendapatan|IRADIMED Inc. - Rega forward marang dodolan|EMBC (Embecta Corp.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep tandemdiabetes.com TNDM|Rasio rega marang prakiraan pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Prakiraan rega marang pendapatan|Bioventus Corp - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake blade.com SRTA|Carlsmed (CARL) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan RXST (RxSight Inc)|Rasio rega marang prakiraan pendapatan ClearPoint Neuro Inc.|Multiplikator forward rega marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator Forward P/S STIM|SGHT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Kapitalisasi marang prakiraan pendapatan|NSPR: Multiplikator forward rega marang pendapatan|Jin Medical International - Rasio rega marang pendapatan sing dikarepake|VANI: Multiplikator Forward P/S|Xtant Medical (XTNT) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan NMTC|Kapitalisasi marang prakiraan pendapatan MODD (Modular Med)|Rasio rega marang prakiraan pendapatan Myomo, Inc (MYO)|COCH - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S VVOS (Vivos Therapeutics)|Prakiraan rega marang pendapatan envveno.com|SINTX Technologies - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Tenon Medical Inc.|ReWalk Robotics Ltd (LFWD) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan AMIX|Multiplikator forward rega marang pendapatan IVF|BBLG: Rega forward marang dodolan|Multiplikator Forward P/S AXNX|Rasio kapitalisasi marang dodolan sing dikarepake BIOLASE Inc.|Rasio rega marang prakiraan pendapatan Dynatronics DYNT|FNA: Kapitalisasi marang prakiraan pendapatan|INVO Bio - Multiplikator Forward P/S
